Skip to main content
. 2021 Apr 5;22(7):3764. doi: 10.3390/ijms22073764
ADA Adenosine deaminase
ADA1 Adenosine deaminase 1
ADA2 Adenosine deaminase 2
ADMA Asymmetric dimethylarginine
Ado Adenosine
ALB Albumin
ALP Alkaline phosphatase
ALT Alanine transaminase
APTT Activated partial thromboplastin time
AR Adenosine receptor
AST Aspartate transaminase
ATP Adenosine triphosphate
BC Breast cancer
BUN Blood urea nitrogen
Ca Calcium
CD39 Ecto-nucleoside triphosphate diphosphohydrolase
CD73 Ecto-5’nucleotidase
CHOL Total cholesterol
CM Cell medium
Creat Creatinine
CRPhs High sensitive C reactive protein
dAdo Deoxyadenosine
dCF Deoxycoformycin
eADA1 Ecto-adenosine deaminase 1
eADA2 Ecto-adenosine deaminase 2
EHNA Erythro-9-(2-hydroxy-3-nonyl)adenine
ER Estrogen receptors
FIB Fibrinogen
Gal3 Galectin 3
Glu Glucose
HDL High density lipoproteins
HER2 Human epidermal growth factor 2
Hgb Hemoglobin
HR Hormone receptors
Ht Hematocrit
HULEC Human lung endothelial cell line
K Potassium
Ki-67/Ki Marker of proliferation Ki-67
LDH Lactate dehydrogenase
LDL Low density lipoproteins
M2 Macrophages M2
MDA-MB-231 Human triple negative breast cancer cell line
Mg Magnesium
N.A. Not available
Na Sodium
Pho Phosphorus
PLT Platelets
PR Progesterone receptors
PT Prothrombin time
RBC Red blood cells
RP-HPLC Reverse phase high performance liquid chromatography
sCD163 Soluble CD163 protein
tADA Total adenosine deaminase
TAMs Tumor associated macrophages
TG Triglycerydes
THP-1 Human monocytes/macrophages line
TILs Tumor infiltrated lymphocytes
TNBC Triple negative breast cancer
VEGF Vascular endothelial growth factor
W APTT Activated partial thromboplastin time factor
WBC White blood cells
WPT Prothrombin time factor